Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
BCL2 interacting protein 3 pseudogene 40 (BNIP3P40)
- Target
- BNIP3P40
- Molecular classification
- Other (Pseudogene)
01
Overview
BCL2 interacting protein 3 pseudogene 40 (BNIP3P40) is a pseudogene, meaning it is a DNA sequence that resembles a functional gene but typically lacks protein-coding capability. Pseudogenes may be transcribed to form non-coding RNAs involved in gene regulation through various mechanisms such as acting as miRNA decoys, antisense RNA, or producing siRNAs, but they generally do not encode functional proteins. BNIP3P40 is classified as a member of the BCL2 interacting protein 3 pseudogene family and does not have direct therapeutic relevance as a drug target[1][2][5].
- Other names
- BCL2/adenovirus E1B 19kDa interacting protein 3 pseudogene 40BNIP3P40
02
Mechanism of action
null (no drug mechanism, only possible regulatory RNA effects as described for some pseudogenes in general[2][5])
03
Biological functions
Gene regulation (via non-coding RNA products and possible epigenetic regulation), but not protein-level functions typical of receptors/enzymes
04
Disease associations
Other (may have indirect regulatory functions in disease via gene expression regulation, as some pseudogenes can act as miRNA decoys or produce non-coding RNAs that influence parental gene expression)
Beyond the preview
Go deeper on BCL2 interacting protein 3 pseudogene 40 (BNIP3P40).
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow the clinical studies evaluating therapies directed at this target.
- Trial design
- Status
- Readouts
Competitive landscape
Full profile accessCompare approaches across drug candidates, modalities, and indications.
- Programs
- Modalities
- Indications
Literature & evidence
Full profile accessInvestigate the research and source evidence behind target biology and development.
- Publications
- Sources
- Analysis
Patents
Full profile accessExplore patent activity around therapies and technologies addressing this target.
- Patents
- Assignees
- Technologies
Research & analysis
Full profile accessConnect target biology, drug development, and emerging evidence in your research.
- Biology
- Development news
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on BCL2 interacting protein 3 pseudogene 40 (BNIP3P40).